Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade F 0.32 3.90% 0.01
CNAT closed up 3.9 percent on Monday, August 19, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CNAT trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Bollinger Band Squeeze Range Contraction 3.90%
Narrow Range Bar Range Contraction 3.90%
Inside Day Range Contraction 3.90%
20 DMA Resistance Bearish 6.67%

Older signals for CNAT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
Medicine Biotechnology Medical Specialties Hepatitis Infectious Causes Of Cancer Hepatology Healthcare Associated Infections Hepatocellular Carcinoma Liver Liver Diseases Organ Transplantation Hepatitis C Virus Infection Liver Fibrosis
Is CNAT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.74
52 Week Low 0.25
Average Volume 1,213,176
200-Day Moving Average 1.6412
50-Day Moving Average 0.4282
20-Day Moving Average 0.3103
10-Day Moving Average 0.3028
Average True Range 0.0391
ADX 11.19
+DI 22.1858
-DI 21.8761
Chandelier Exit (Long, 3 ATRs ) 0.2727
Chandelier Exit (Short, 3 ATRs ) 0.3674
Upper Bollinger Band 0.3367
Lower Bollinger Band 0.2839
Percent B (%b) 0.68
BandWidth 17.015791
MACD Line -0.0292
MACD Signal Line -0.0405
MACD Histogram 0.0113
Fundamentals Value
Market Cap 9.6 Million
Num Shares 30 Million
EPS -0.98
Price-to-Earnings (P/E) Ratio -0.33
Price-to-Sales 7.70
Price-to-Book 4.00
PEG Ratio -0.23
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.37
Resistance 3 (R3) 0.37 0.35 0.36
Resistance 2 (R2) 0.35 0.34 0.35 0.36
Resistance 1 (R1) 0.34 0.33 0.35 0.34 0.35
Pivot Point 0.32 0.32 0.33 0.32 0.32
Support 1 (S1) 0.30 0.31 0.31 0.30 0.29
Support 2 (S2) 0.29 0.30 0.29 0.28
Support 3 (S3) 0.27 0.29 0.28
Support 4 (S4) 0.27